FindTrial
Sign In

A Single-center Randomized Controlled Trial About 3-D Printing Personalized Augment for Treating Acetabular Bone Defect

A Single-center Randomized Controlled Trial About 3-D Printing Personalized Augment for Treating Acetabular Bone Defect

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013267
Enrollment
Unknown
Registered
2017-11-06
Start date
2017-11-11
Completion date
Unknown
Last updated
2017-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acetabular bone defect

Interventions

Treatment group:3D printing personalized augment
Control group:Tantalum augment

Sponsors

Chinese People's Liberation Army General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 75 years old; 2. Acetabular Bone Defect patients undergoing primary or revision total hip arthroplasty; 3. Informed consent was signed.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart, brain, liver, kidney dysfunction; 2. Intra-operative complications affect postoperative recovery; 3. Patients with mental illness or acataphasia; 4. To participate in other clinic trials in two months; 5. Patients were unwilling to sign informed consent or to compliance trial program.

Design outcomes

Primary

MeasureTime frame
Hip Harris Score and WOAMC Score;—

Secondary

MeasureTime frame
Prosthesis Bone ingrowth;Complications;—

Countries

Chian

Contacts

Public ContactJiying Chen

Chinese People's Liberation Army General Hospital

jiyingchen_301@163.com+86 15110102939

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026